News

London-based buyout firm CapVest Partners is in talks to acquire a majority stake in German drugmaker Stada Arzneimittel, ...
His genome held strange secrets: a turbocharged alcohol gene, rewired brain chemistry, and a slow-burn caffeine receptor.